Respicardia Inc.

Founded in 2006 and headquartered in Minneapolis, Minnesota, Respicardia is improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health. The first product, the remedē™ system, is an implantable stimulation device that is designed to restore a more regular breathing pattern during sleep for patients with central sleep apnea. Respicardia is committed to improving cardiovascular health – one breath at a time.